Breast cancer classification divides all forms of breast cancer according to four different schemes, each based on different criteria and serving a different purpose. The four approaches consider pathology, the grade of the tumor, expression of proteins and genes, and the stage of the tumor.

Classifications of breast cancer are usually, but not always, classified by the histological appearance of tissue in the tumor. Rare variants are defined on the basis of physical exam findings. For example, Inflammatory breast cancer (IBC), a form of ductal carcinoma or malignant cancer in the ducts, is distinguished from other carcinomas by the inflamed appearance of the affected breast.^[1] In the future, some pathologic classifications may be changed. For example, a subset of ductal carcinomas may be re-named basal-like carcinoma (part of the "triple-negative" tumors).^{[citation needed]}

Contents 1 Major schemes 2 Staging 3 Pathologic types 4 Malignant disease gallery 5 Non-malignant disease gallery 6 References

[edit] Major schemes

• Pathology - A pathologist will categorize each tumor based on its histological (microscopic anatomy) appearance and other criteria. The most common pathologic types of breast cancer are invasive ductal carcinoma, malignant cancer in the breast's ducts, and invasive lobular carcinoma, malignant cancer in the breast's lobules.
• Grade of tumor - The histological grade of a tumor is determined by a pathologist under a microscope using the Bloom-Richardson grade system. A well-differentiated (low grade) tumor resembles normal tissue. A poorly differentiated (high grade) tumor is composed of disorganized cells and, therefore, does not look like normal tissue. Moderately differentiated (intermediate grade) tumors are somewhere in between.
• Protein & gene expression status - Currently, all breast cancers should be tested for expression, or detectable effect, of the estrogen receptor (ER), progesterone receptor (PR) and HER2/neu proteins. (If none of these 3 is relevant then the cancer is a triple negative breast cancer.) These tests are usually done by immunohistochemistry and are presented in a pathologist's report. The profile of expression of a given tumor helps predict its prognosis, or outlook, and helps an oncologist choose the most appropriate treatment. More genes and/or proteins may be tested in the future (eg PAX2^[2]).
• Stage of a tumor - The currently accepted staging scheme for breast cancer is the TNM classification.

[edit] Staging

Tumor - There are five tumor classification values (Tis, T1, T2, T3 or T4) which depend on the presence or absence of invasive cancer, the dimensions of the invasive cancer, and the presence or absence of invasion outside of the breast (e.g. to the skin of the breast, to the muscle or to the rib cage underneath):

• Tx - Primary tumor cannot be assessed.
• T0 - No evidence of primary tumor.
• Tis - Carcinoma in situ.
  • Tis(DCIS) - Intraductal Carcinoma in situ.
  • Tis(LCIS) - Lobular Carcinoma in situ.
  • Tis(Paget's) - Paget's disease of the nipple with no tumor.
• T1 - Tumor 2 cm or less in its greatest dimension.
  • T1mic - Microinvasion 0.1 cm or less in greatest dimension.
  • T1a - Tumor more than 0.1 cm but not more than 0.5 cm in its greatest dimension.
  • T1b - Tumor more than 0.5 cm but not more than 1.0 cm in its greatest dimension.
  • T1c - Tumor more than 1.0 cm but not more than 2.0 cm in its greatest dimension.
• T2 - Tumor more than 2.0 cm but not more than 5.0 cm in its greatest dimension.
• T3 - Tumor more than 5 cm in its greatest dimension.
• T4 - Tumor of any size with direct extension to (a) chest wall or (b) skin as described below:
  • T4a - Extension to chest wall.
  • T4b - Edema (including peau d'orange) or ulceration of the breast skin, or satellite skin nodules confined to the same breast.
  • T4c - Both T4a and T4b.
  • T4d - Inflammatory breast cancer.

Lymph Node - There are four lymph node classification values (N0, N1, N2 or N3) which depend on the number, size and location of breast cancer cell deposits in lymph nodes.

• Nx - regional lymph nodes cannot be assessed. Perhaps due to previous removal.
• N0 - no regional lymph node metastasis.
• N1 - metastasis to movable regional axillary lymph nodes on the same side as the affected breast.
• N2 - metastasis to fixed regional axillary lymph nodes, or metastasis to the internal mammary lymph nodes, on the same side as the affected breast.
• N3 - metastasis to supraclavicular lymph nodes or infraclavicular lymph nodes or metastasis to the internal mammary lymph nodes with metastasis to the axillary lymph nodes.

Metastases - There are two metastatic classification values (M0 or M1) which depend on the presence or absence of breast cancer cells in locations other than the breast and lymph nodes (so-called distant metastases, e.g. to bone, brain, lung).

[edit] Pathologic types

The latest (2003) World Health Organization (WHO) classification of tumors of the breast^[3] recommends the following pathological types, which includes benign (harmless) tumors along with malignant (cancerous) tumors:

Invasive breast carcinomas Invasive ductal carcinoma Most are "not otherwise specified" The remainder are given subtypes: Mixed type carcinoma Pleomorphic carcinoma Carcinoma with osteoclastic giant cells Carcinoma with choriocarcinomatous features Carcinoma with melanotic features Invasive lobular carcinoma Tubular carcinoma Invasive cribriform carcinoma Medullary carcinoma Mucinous carcinoma and other tumours with abundantmucin Mucinous carcinoma Cystadenocarcinoma and columnar cell mucinous carcinoma Signet ring cell carcinoma Neuroendocrine tumours Solid neuroendocrine carcinoma (carcinoid of the breast) Atypical carcinoid tumour Small cell / oat cell carcinoma Large cell neuroendocrine carcioma Invasive papillary carcinoma Invasive micropapillary carcinoma Apocrine carcinoma Metaplastic carcinomas Pure epithelial metaplastic carciomas Squamous cell carcinoma Adenocarcinoma with spindle cell metaplasia Adenosquamous carcinoma Mucoepidermoid carcinoma Mixed epithelial/mesenchymal metaplastic carcinomas Lipid-rich carcinoma Secretory carcinoma Oncocytic carcinoma Adenoid cystic carcinoma Acinic cell carcinoma Glycogen-rich clear cell carcinoma Sebaceous carcinoma Inflammatory carcinoma Bilateral breast carcinoma Mesenchymal tumors (including sarcoma) Haemangioma Angiomatosis Haemangiopericytoma Pseudoangiomatous stromal hyperplasia Myofibroblastoma Fibromatosis (aggressive) Inflammatory myofibroblastic tumour Lipoma Angiolipoma Granular cell tumour Neurofibroma Schwannoma Angiosarcoma Liposarcoma Rhabdomyosarcoma Osteosarcoma Leiomyoma Leiomysarcoma

Precursor lesions Lobular neoplasia lobular carcinoma in situ Intraductal proliferative lesions Usual ductal hyperplasia Flat epithelial hyperplasia Atypical ductal hyperplasia Ductal carcinoma in situ Microinvasive carcinoma Intraductal papillary neoplasms Central papilloma Peripheral papilloma Atypical papilloma Intraductal papillary carcinoma Intracystic papillary carcinoma Benign epithelial lesions Adenosis, including variants Sclerosing adenosis Apocrine adenosis Blunt duct adenosis Microglandular adenosis Adenomyoepithelial adenosis Radial scar / complex sclerosing lesion Adenomas Tubular adenoma Lactating adenoma Apocrine adenoma Pleomorphic adenoma Ductal adenoma Myoepithelial lesions Myoepitheliosis Adenomyoepithelial adenosis Adenomyoepithelioma Malignant myoepithelioma Fibroepithelial tumours Fibroadenoma Phyllodes tumour Benign Borderline Malignant Periductal stromal sarcoma, low grade Mammary hamartoma Tumours of the nipple Nipple adenoma Syringomatous adenoma Paget's disease of the nipple Malignant lymphoma Metastatic tumours Tumours of the male breast Gynecomastia Carcinoma In situ Invasive

[edit] Malignant disease gallery

Infiltrating ductal carcinoma of the Breast assayed with anti Mucin 1 antibody	Breast cancer (Infiltrating ductal carcinoma of the breast) assayed with anti HER-2 (ErbB2) antibody	Invasive lobular carcinoma of the breast demonstrating a predominantly lobular growth pattern	Metaplastic (sarcomatoid) carcinoma of the breast.
Histopathologic image from ductal cell carcinoma in situ (DCIS) of breast. Hematoxylin-eosin stain.	Histopathology of invasive ductal carcinoma of the breast representing a scirrhous growth. Core needle biopsy. Hematoxylin and eosin stain.	Histopathology of invasive ductal carcinoma of the breast representing a scirrhous growth. Core needle biopsy. HER-2/neu oncoprotein expression by Ventana immunostaining system.	Invasive ductal carcinoma of the breast. H&E stain.
Breast carcinoma metastatic to a lymph node. H&E stain.	Breast carcinoma with signet ring cell morphology. H&E stain.

[edit] Non-malignant disease gallery

Histopathology of intraductal papilloma of the breast by excisional biopsy. Immunostaining for alpha-smooth muscle actin.	Histopathology of intraductal papilloma of the breast by excisional biopsy. Immunostaining for p63 protein.	Breast fibroadenoma	Breast fibroadenoma
Histopathologic image of breast fibroadenoma. Core needle biopsy. Hematoxylin & eosin stain.	Histopathologic image of breast fibroadenoma. Core needle biopsy. Hematoxylin & eosin stain.	Histopathology of intraductal papilloma of the breast by excisional biopsy. Hematoxylin and eosin stain.	Histopathology of intraductal papilloma of the breast by excisional biopsy. Immunostaining for alpha-smooth muscle actin.
Histopathology of intraductal papilloma of the breast by excisional biopsy. Immunostaining for p63 protein.	Micrograph of a benign Phyllodes tumor. H&E stain.

[edit] References

v • d • e Breast cancer Main article · Risk factors (Alcohol) · Screening · Treatment · Ductal carcinoma

v • d • e Tumors: breast cancer (C50/D24, 174-175/217) Fibroepithelial/stromal Fibroadenoma · Phyllodes tumor Ductal, lobular, and medullary Ductal Ductal carcinoma in situ (DCIS): Paget's disease of the breast · Comedocarcinoma Invasive ductal carcinoma (IDC) Lobular Lobular carcinoma in situ (LCIS) Invasive lobular carcinoma (ILC) Medullary Medullary carcinoma Other/ungrouped Inflammatory breast cancer Precursor lesions Atypical ductal hyperplasia breast navs: anat/physio, noncongen/congenital/neoplasia, proc